Singhal Priya's Form 4 filing
Biogen Inc. (BIIB) · filed Sep 6, 2023
- Accession no.
- 0001127602-23-023824
- Filed
- Sep 6, 2023
- Trade date
- Sep 1-5, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $116.1K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Singhal PriyaCIK 0001769608 | Officer (Head of Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | MOption exerciseAcquired | +1,668 | $0.00 | $0 | 4,592.09 | Direct | |
| Sep 1, 2023 | Common Stock | FTax withholdingDisposed | −807 | $267.17 | −$215,606.19 | 3,785.09 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −431 | $269.43 | −$116,124.33 | 3,354.09 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | MOption exerciseDisposed | −1,668 | $0.00 | $0 | 3,337 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.